Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P61278 (
somatostatin
)
22,083
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. The application of in situ hybridization histochemistry to the study of neuropeptide gene expression in human brain postmortem tissues is reviewed. We focus on neuropeptides preferentially expressed in hypothalamus and basal ganglia. 32P-labeled oligonucleotides were used as hybridization probes. 2. Autoradiography combined with computerized image analysis was used to visualize and quantify the hybridization signal. 3. Several criteria were considered in order to ascertain the specificity of the signal, including Northern analysis, use of heterologous probes, competition assays, and thermal stability of the hybrids. 4. In control human striatum high levels of hybridization signal were observed for
somatostatin
, neuropeptide Y, and
preproenkephalin
A mRNAs. In contrast, no detectable signal was observed with the cholecystokinin, arginine-vasopressin, and oxytocin probes in this area. In the hypothalamus high levels of oxytocin and arginine-vasopressin mRNAs were visualized in several nuclei. Preproenkephalin A and
somatostatin
mRNAs were also observed in this region, while cholecystokinin mRNA was not detected. 5. No significant correlations were found between the density of the hybridization signal and parameters such as postmortem delay, age, and gender in the population studied. 6. Finally, alterations of mRNA levels for some of these peptides were found in Parkinson's disease and Huntington's chorea striatal tissues. 7. These results show that in situ hybridization histochemistry can be used to examine at the microscopic level neuropeptide gene expression in postmortem materials.
...
PMID:The use of in situ hybridization histochemistry for the study of neuropeptide gene expression in the human brain. 233 44
Neurons surrounding the central canal in sacral spinal segments were functionally characterized on the basis of somatic and/or visceral afferent input, then intracellularly marked with horseradish peroxidase (HRP). Tissue sections containing portions of HRP-stained neurons were subsequently immunohistochemically examined for the presence of contacts made by axonal enlargements containing vasoactive intestinal polypeptide (VIP), substance P (SP),
somatostatin
(SS),
Leu-enkephalin
(ENK), or serotonin (5-HT). ENK-and 5-HT-containing enlargements were found to contact all neurons examined. SP and SS terminals contacted fewer neurons, and were not associated with specific functional classes. On the other hand, VIP-containing fibers contacted only those neurons receiving visceral afferent input, thus supporting the contention that VIP is contained in a population of visceral afferent fibers projecting to the gray matter surrounding the central canal at sacral levels.
...
PMID:Immunohistochemistry of synaptic input and functional characterizations of neurons near the spinal central canal. 241 42
The recovery of RNA from postmortem (PM) brain tissues was quantified by molecular hybridization. RNA degradation rates postmortem were faster in mice with herpes encephalitis than with uninfected mice, but clear ribosomal peaks could be seen up to 72 hr after death. In a comparison between frontal cortex samples from neurologically normal and Alzheimer's disease cases a reduction in ribosomal, poly A,
preproenkephalin
, and
preprosomatostatin
RNA levels was observed in the Alzheimer's disease group. This general reduction may be influenced by the cause of death as well as the pathology.
...
PMID:Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization. 241 56
The subcellular distribution of noradrenaline (NA), neuropeptide Y (NPY), Met- and
Leu-enkephalin
(ENK), substance P (SP),
somatostatin
(
SOM
), and vasoactive intestinal polypeptide (VIP) was investigated in homogenates of bovine splenic nerve. The distribution of noradrenergic peptide-containing nerves in the bovine celiac ganglion, splenic nerve and terminal areas in spleen was studied by indirect immunofluorescence histochemistry using antisera to tyrosine hydroxylase (TH), dopamine-beta-hydroxylase (DBH), NPY, enkephalin peptides, SP,
SOM
, VIP, and peptide HI (PHI). After density gradient centrifugation, high levels of NPY- and ENK-like immunoreactivity (LI) were found in high-density gradient fractions, coinciding with the main NA peak. SP,
SOM
and VIP were found in fractions with a lower density, VIP being also enriched in a heavy fraction; the latter three peptides were present in low concentrations. Immunohistochemistry revealed that staining for NPY-LI and ENK-LI partly overlapped that for TH and DBH in celiac ganglia, splenic nerve axons and terminal areas of spleen. Almost all principal ganglion cells were TH- and DBH-immunoreactive. Many were also NPY-immunoreactive, whereas a smaller number were ENK-positive. In the celiac ganglion patches of dense SP-positive networks and some VIP/PHI- and ENK-immunoreactive fibers were seen around cell bodies. The results indicate that NPY and ENK are stored with NA in large dense-cored vesicles in unmyelinated axons of bovine splenic nerve. SP,
SOM
and VIP appear in different organelles in axon populations separate from sympathetic noradrenergic nerves.
...
PMID:Neuropeptide Y, enkephalin and noradrenaline coexist in sympathetic neurons innervating the bovine spleen. Biochemical and immunohistochemical evidence. 242 Apr 59
A whole mount immunofluorescence method was used for the localization of immunoreactivity (IR) to four regulatory peptides and the bioamine serotonin in the nervous system of Stenostomum leucops (Turbellaria, Platyhelminthes). The flatworm S. leucops belongs to the taxon Catenulida which, according to the new phylogenetic system by Ax [2], forms a key group between the coelenterates and more advanced flatworm species. Positive IR was obtained using antisera against FMRF-amide, beta-endorphin, growth hormone releasing factor (GRF), substance P, and serotonin. The distribution patterns of these neuropeptide-like immunoreactivities differ significantly from each other. Antisera against
Leu-enkephalin
, bovine pancreatic polypeptide (BPP), bombesin, cholecystokinin (CCK-8), neurotensin,
somatostatin
, growth hormone (GH), secretin, and neurophysin II gave negative results. This primitive flatworm shows similarities with hydra in the lack of IR to anti-
somatostatin
, anti-
Leu-enkephalin
, and anti-BPP. These antisera give positive IR in more advanced flatworm species, indicating a later convergent evolution of vertebrate-like peptides within the phylum Platyhelminthes.
...
PMID:Neuropeptides in a microturbellarian--whole mount immunocytochemistry. 242 Dec 67
The immunoreactivity of anti-neuron-specific enolase (NSE) and anti-Leu-7 on formalin-fixed sections of human fetal salivary gland epithelium was determined by the avidin-biotin-peroxidase complex (ABC) method. In addition, expression of some neuropeptides such as vasoactive intestinal polypeptide (VIP),
somatostatin
(SRIF), and substance P in the human salivary gland epithelium during the gestational period was observed, whereas the other polypeptides examined, including glucagon, cholecystokinin (CCK),
Leu-enkephalin
, and calcitonin were absent. NSE and Leu-7 immunoreactivity in the fetal salivary gland epithelium was observed solitarily or in groups commonly restricted to the developing duct epithelium. Positive immunoreactivity was observed in 46 cases with NSE (73%) and 44 cases with Leu-7 (70%) in 63 fetal salivary glands examined. In contrast, the incidence of positive cases stained with neuropeptides was lower than those of NSE and Leu-7 immunoreactivity in the human fetal salivary gland epithelium. These findings indicate that certain neuropolypeptides, as well as VIP, SRIF, and substance P present in the human fetal salivary gland epithelium may play a significant role in the development of the gland.
...
PMID:Expression of neuron-specific enolase, Leu-7, and neuropeptides in human fetal salivary gland epithelium. 247 26
Specific binding sites for
somatostatin
have been identified and characterized in cytosolic fraction of rabbit gastric mucosa at both antrum and fundus levels. The binding depended on time, temperature and pH, and was reversible and saturable. The stoichiometric data suggested the presence of two classes of binding sites: a class with high affinity (Kd = 26.7 and 37.0 nM in antrum and fundus, respectively) and low capacity (2.1 and 4.1 pmol
somatostatin
/mg protein in antrum and fundus, respectively), and a class with low affinity (Kd = 246.4 and 162.5 nM in antrum and fundus, respectively) and high capacity (134.1 and 110.9 pmol
somatostatin
/mg protein in antrum and fundus, respectively) at 25 degrees C and pH 7.4. The binding sites were shown to be highly specific for
somatostatin
since neuropeptides such as
Leu-enkephalin
, neurotensin and substance P behaved as ligands with very low affinity.
...
PMID:Somatostatin binding sites in cytosolic fraction isolated from rabbit antral and fundic gastric mucosa. 285 38
Specific binding sites for
somatostatin
have been identified in cytosolic fraction of both small and large intestinal mucosa. The stoichiometric data suggested the presence of two classes of binding sites in each part of the intestine. The binding capacity varied depending on the segment considered (rectum greater than duodenum = jejunum greater than ileum, caecum and colon). However, the affinities of the binding sites were similar throughout the whole intestinal mucosa, with the exception of rectum which showed higher Kd values. The binding sites were shown to be highly specific for
somatostatin
since neuropeptides such as vasoactive intestinal peptide, neurotensin, substance P and
Leu-enkephalin
did not show any effect upon
somatostatin
binding.
...
PMID:Somatostatin binding sites in cytosolic fraction of rabbit intestinal mucosa: distribution throughout the intestinal tract. 286 19
The ability of certain neuropeptides (glucagon,
somatostatin
, leu-enkephalin and neurotensin) to release known neurotransmitters (glycine, GABA, dopamine and 5-hydroxytryptamine) was tested in the chicken retina. Tritiated neurotransmitters were injected intravitreally in chicken eyes. After excision, the retina was stimulated in vitro with the neuropeptide in micromolar concentrations while monitoring the efflux of radioactivity from the retina. A rise of the efflux represents a stimulus dependent release. Neurotensin release [3H] glycine, [3H]dopamine and [3H]5-hydroxytryptamine.
Leu-enkephalin
released [3H]dopamine and
somatostatin
released [3H]5-hydroxytryptamine. Glucagon was without effect. [3H]GABA was not released by any of the neuropeptides.
...
PMID:Neurotransmitter release by certain neuropeptides in the chicken retina. 286 56
Specific binding sites for
somatostatin
have been identified in cytosolic fraction of rabbit kidney (cortex and outer medulla) using 125I-Tyr11-
somatostatin
. The binding was saturable and reversible, as well as time and temperature dependent. Optimal pH for binding was observed at about 7.4. Scatchard plots were compatible with the existence of two classes of binding sites: a first class with a high affinity (Kd = 40 nM) and a low binding capacity (2.0 pmol
somatostatin
/mg protein) and a second class with a low affinity (Kd = 222 nM) and a high binding capacity (114.3 pmol
somatostatin
/mg protein). Vasoactive intestinal peptide, neurotensin, substance P,
Leu-enkephalin
and vasopressin had practically no effect on
somatostatin
binding. The properties of these binding sites strongly support the concept that
somatostatin
could behave as a regulatory peptide on the rabbit kidney.
...
PMID:Evidence for somatostatin binding sites in rabbit kidney. 287 91
<< Previous
1
2
3
4
5
6
7
Next >>